JP7458185B2 - 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル - Google Patents

改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル Download PDF

Info

Publication number
JP7458185B2
JP7458185B2 JP2019529204A JP2019529204A JP7458185B2 JP 7458185 B2 JP7458185 B2 JP 7458185B2 JP 2019529204 A JP2019529204 A JP 2019529204A JP 2019529204 A JP2019529204 A JP 2019529204A JP 7458185 B2 JP7458185 B2 JP 7458185B2
Authority
JP
Japan
Prior art keywords
human
cells
mouse
mice
immunodeficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019529204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019536457A5 (https=
JP2019536457A (ja
Inventor
ディー． シュルツ，レオナルド
ジー． ケック，ジェームス
エル． グライナー，デール
エー． ブレーム，マイケル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jackson Laboratory
Original Assignee
Jackson Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jackson Laboratory filed Critical Jackson Laboratory
Publication of JP2019536457A publication Critical patent/JP2019536457A/ja
Publication of JP2019536457A5 publication Critical patent/JP2019536457A5/ja
Priority to JP2022166015A priority Critical patent/JP2023015064A/ja
Application granted granted Critical
Publication of JP7458185B2 publication Critical patent/JP7458185B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2019529204A 2016-11-30 2017-11-30 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル Active JP7458185B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022166015A JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662428131P 2016-11-30 2016-11-30
US62/428,131 2016-11-30
US201762565783P 2017-09-29 2017-09-29
US62/565,783 2017-09-29
PCT/US2017/063948 WO2018102546A1 (en) 2016-11-30 2017-11-30 Humanized mouse model with improved human innate immune cell development

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022166015A Division JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Publications (3)

Publication Number Publication Date
JP2019536457A JP2019536457A (ja) 2019-12-19
JP2019536457A5 JP2019536457A5 (https=) 2021-01-21
JP7458185B2 true JP7458185B2 (ja) 2024-03-29

Family

ID=60935945

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529204A Active JP7458185B2 (ja) 2016-11-30 2017-11-30 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル
JP2022166015A Pending JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022166015A Pending JP2023015064A (ja) 2016-11-30 2022-10-17 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル

Country Status (5)

Country Link
US (3) US20190320633A1 (https=)
EP (1) EP3547831B1 (https=)
JP (2) JP7458185B2 (https=)
CN (1) CN110740641A (https=)
WO (1) WO2018102546A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110740641A (zh) * 2016-11-30 2020-01-31 杰克逊实验室 具有改善的人先天免疫细胞发育的人源化小鼠模型
SG10202112528QA (en) 2017-05-12 2021-12-30 Jackson Lab Nsg mice lacking mhc class i and class ii
US11712026B2 (en) 2017-10-18 2023-08-01 The Jackson Laboratory Murine-MHC-deficient HLA-transgenic nod-mouse models for T1D therapy development
US20210355501A1 (en) * 2018-09-24 2021-11-18 Albert Einstein College Of Medicine Interleukin-8 for maintenance of human acute myeloid leukemia and myelodysplastic syndrome and uses thereof
CN113614238B (zh) * 2019-03-28 2024-10-22 公益财团法人实中研 免疫缺陷小鼠
US20220312749A1 (en) * 2019-08-09 2022-10-06 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
CN111705082A (zh) * 2020-04-14 2020-09-25 澎立生物医药技术（上海）有限公司 具有髓系免疫细胞的人源化免疫系小鼠的构建方法
CN116322317B (zh) * 2020-07-08 2025-12-12 杰克逊实验室 表达人hla-a201限制基因的转基因小鼠模型
JP2023542539A (ja) 2020-09-24 2023-10-10 ザ ジャクソン ラボラトリー 免疫細胞療法を評価するためのヒト化マウスモデル
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用
AU2022421979A1 (en) * 2021-12-22 2024-08-01 The Jackson Laboratory Humanized mouse models
CA3260932A1 (en) 2022-06-30 2024-01-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services CD25-SPECIFIC ANTIBODIES AND THEIR USES
CA3266908A1 (en) * 2022-09-08 2024-03-14 The Jackson Laboratory HUMANIZED IMMUNODEFICIENT MURINE MODELS
EP4608969A1 (en) * 2022-10-25 2025-09-03 Lapix Therapeutics, Inc. Immune cell-engrafted non-human animals and non-human animal models
WO2025041060A1 (en) * 2023-08-21 2025-02-27 VeraVerse Co., Ltd. Patient-derived xenograft model of cancer, preparation method thereof and an apparatus and a method for analyzing drug responsiveness using the same
WO2026001958A1 (zh) * 2024-06-24 2026-01-02 黄菁 Aav载体、aav载体的组合、构建aml pdx和mm pdx非人动物的方法及构建免疫系统人源化非人动物的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003508038A (ja) 1999-08-31 2003-03-04 ジェネンコア インターナショナル インコーポレーテッド ドナー特異的機能性免疫の産生を容易にすることができるトランスジェニック哺乳類
JP2015529083A (ja) 2012-09-07 2015-10-05 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005295269B2 (en) 2004-10-19 2010-05-13 Regeneron Pharmaceuticals, Inc. Method for generating an animal homozygous for a genetic modification
MX350385B (es) * 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
CA2887706C (en) * 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
ES2715949T3 (es) 2013-10-15 2019-06-07 Regeneron Pharma Animales con IL-15 humanizada
US20150282460A1 (en) 2014-04-04 2015-10-08 Crown Bioscience Inc. (Taicang) Animal model with human immune system
SG10202002187WA (en) * 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
KR102658190B1 (ko) 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトｉｌ−１５分泌免疫不全マウス
KR102664078B1 (ko) * 2015-06-23 2024-05-10 더 잭슨 래보라토리 환자-유래 이종이식을 가지는 hla-비매칭의 인간화된 nsg 마우스 모델
EP3367787A1 (en) 2015-10-30 2018-09-05 The Jackson Laboratory Compositions and methods relating to tumor analysis
RU2019115976A (ru) 2016-10-27 2020-11-27 Зэ Джэксон Лэборэтори Модель с использованием генетически модифицированной мыши для ксенотрансплантации гепатоцитов человека
CN110740641A (zh) * 2016-11-30 2020-01-31 杰克逊实验室 具有改善的人先天免疫细胞发育的人源化小鼠模型
US11084863B2 (en) * 2017-06-30 2021-08-10 Xencor, Inc. Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
WO2019032836A1 (en) 2017-08-09 2019-02-14 The Jackson Laboratory IMMUNODEFICIENT MOUSE EXPRESSING THE HUMAN INTERLEUKINE 15
TWI838389B (zh) 2018-07-19 2024-04-11 美商再生元醫藥公司 雙特異性抗-BCMAｘ抗-CD3抗體及其用途
JP2022512781A (ja) 2018-10-30 2022-02-07 マジェンタ セラピューティクス インコーポレイテッド 同種造血幹細胞移植の方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003508038A (ja) 1999-08-31 2003-03-04 ジェネンコア インターナショナル インコーポレーテッド ドナー特異的機能性免疫の産生を容易にすることができるトランスジェニック哺乳類
JP2015529083A (ja) 2012-09-07 2015-10-05 イエール ユニバーシティ 遺伝学的に修飾された非ヒト動物およびその使用法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Ｂｌｏｏｄ，２０１１年，Ｖｏｌ．１１７，Ｎｏ．１１，ｐｐ．３０７６－３０８６
Ｌｅｕｋｅｍｉａ，２０１０年，Ｖｏｌ．２４，ｐｐ．１７８５－１７８８

Also Published As

Publication number Publication date
WO2018102546A1 (en) 2018-06-07
CN110740641A (zh) 2020-01-31
US12409237B1 (en) 2025-09-09
US20260033467A1 (en) 2026-02-05
JP2023015064A (ja) 2023-01-31
WO2018102546A8 (en) 2018-08-02
EP3547831B1 (en) 2026-04-01
JP2019536457A (ja) 2019-12-19
US20190320633A1 (en) 2019-10-24
EP3547831A1 (en) 2019-10-09

Similar Documents

Publication Publication Date Title
JP7458185B2 (ja) 改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル
JP2024009054A (ja) ヒトｅｐｏを発現する遺伝子改変された非ヒト動物
US20210051928A1 (en) Genetically modified non-human animal with human or chimeric il15
JP7129426B2 (ja) Ｍｈｃクラスｉおよびｍｈｃクラスｉｉを欠損しているｎｓｇマウス
JP7404237B2 (ja) ヒトインターロイキン１５を発現する免疫不全マウス
WO2021136537A1 (en) GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα/CD47
Oravecz-Wilson et al. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts
JP2025521580A (ja) ヒト化ｃｌｅｃ９ａ遺伝子を有する非ヒト動物
CN108471732A (zh) 与肿瘤分析相关的组合物和方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201202

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211001

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220104

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220301

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220617

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221017

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20221017

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20221025

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20221125

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20221128

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230120

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240318

R150 Certificate of patent or registration of utility model

Ref document number: 7458185

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150